118 related articles for article (PubMed ID: 8603374)
1. Inhibitory effect of iridoids on Epstein-Barr virus activation by a short-term in vitro assay for anti-tumor promoters.
Kapadia GJ; Sharma SC; Tokuda H; Nishino H; Ueda S
Cancer Lett; 1996 Apr; 102(1-2):223-6. PubMed ID: 8603374
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of Epstein-Barr virus activation by Citrus fruits, a cancer chemopreventor.
Iwase Y; Takemura Y; Ju-ichi M; Kawaii S; Yano M; Okuda Y; Mukainaka T; Tsuruta A; Okuda M; Takayasu J; Tokuda H; Nishino H
Cancer Lett; 1999 May; 139(2):227-36. PubMed ID: 10395183
[TBL] [Abstract][Full Text] [Related]
3. Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens.
Konoshima T; Takasaki M; Tokuda H; Nishino H
Cancer Lett; 2000 Aug; 157(1):87-92. PubMed ID: 10893446
[TBL] [Abstract][Full Text] [Related]
4. Studies on the inhibitory effects of some acridone alkaloids on Epstein-Barr virus activation.
Takemura Y; Ju-ichi M; Ito C; Furukawa H; Tokuda H
Planta Med; 1995 Aug; 61(4):366-8. PubMed ID: 7480187
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of quassinoids on Epstein-Barr virus activation.
Okano M; Fukamiya N; Tagahara K; Tokuda H; Iwashima A; Nishino H; Lee KH
Cancer Lett; 1995 Aug; 94(2):139-46. PubMed ID: 7634241
[TBL] [Abstract][Full Text] [Related]
6. Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation.
Murakami A; Takahashi M; Jiwajinda S; Koshimizu K; Ohigashi H
Biosci Biotechnol Biochem; 1999 Oct; 63(10):1811-2. PubMed ID: 10586508
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumor. II.
Konoshima T; Takasaki M; Kozuka M; Nagao T; Okabe H; Irino N; Nakasumi T; Tokuda H; Nishino H
Biol Pharm Bull; 1995 Feb; 18(2):284-7. PubMed ID: 7742799
[TBL] [Abstract][Full Text] [Related]
8. Xanthones as inhibitors of Epstein-Barr virus activation.
Ito C; Itoigawa M; Furukawa H; Rao KS; Enjo F; Bu P; Takayasu J; Tokuda H; Nishino H
Cancer Lett; 1998 Oct; 132(1-2):113-7. PubMed ID: 10397461
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation by natural colorants.
Kapadia GJ; Balasubramanian V; Tokuda H; Iwashima A; Nishino H
Cancer Lett; 1997 May; 115(2):173-8. PubMed ID: 9149121
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of stabilized analogues of glycoglycerolipids on Epstein-Barr virus activation and mouse skin tumor promotion.
Colombo D; Compostella F; Ronchetti F; Reza-Elahi S; Scala A; Toma L; Aoi W; Kuchide M; Takayasu J; Tokuda H; Nishino H
Cancer Lett; 2002 Dec; 186(1):37-41. PubMed ID: 12183073
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum.
Itoigawa M; Ito C; Tan HT; Kuchide M; Tokuda H; Nishino H; Furukawa H
Cancer Lett; 2001 Aug; 169(1):15-9. PubMed ID: 11410320
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of monoacylated 2-O-beta-galactosylglycerols on Epstein-Barr virus activation: the significant role of the hexanoyl chain.
Colombo D; Compostella F; Ronchetti F; Scala A; Toma L; Mukainaka T; Nagatsu A; Konoshima T; Tokuda H; Nishino H
Cancer Lett; 1999 Aug; 143(1):1-4. PubMed ID: 10465330
[TBL] [Abstract][Full Text] [Related]
13. Screening of tissue cultures and thalli of lichens and some of their active constituents for inhibition of tumor promoter-induced Epstein-Barr virus activation.
Yamamoto Y; Miura Y; Kinoshita Y; Higuchi M; Yamada Y; Murakami A; Ohigashi H; Koshimizu K
Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1388-90. PubMed ID: 7553984
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects on Epstein-Barr virus activation of anthraquinones: correlation with redox potentials.
Koyama J; Tagahara K; Osakai T; Tsujino Y; Tsurumi S; Nishino H; Tokuda H
Cancer Lett; 1997 May; 115(2):179-83. PubMed ID: 9149122
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of natural carotenoids on Epstein-Barr virus activation activity of a tumor promoter in Raji cells. A screening study for anti-tumor promoters.
Tsushima M; Maoka T; Katsuyama M; Kozuka M; Matsuno T; Tokuda H; Nishino H; Iwashima A
Biol Pharm Bull; 1995 Feb; 18(2):227-33. PubMed ID: 7742789
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of herbal remedies on 12-O-tetradecanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activation.
Kapadia GJ; Azuine MA; Tokuda H; Hang E; Mukainaka T; Nishino H; Sridhar R
Pharmacol Res; 2002 Mar; 45(3):213-20. PubMed ID: 11884218
[TBL] [Abstract][Full Text] [Related]
17. Chalcone tetramers, lophirachalcone and alatachalcone, from Lophira alata as possible anti-tumor promoters.
Murakami A; Tanaka S; Ohigashi H; Hirota M; Irie R; Takeda N; Tatematsu A; Koshimizu K
Biosci Biotechnol Biochem; 1992 May; 56(5):769-72. PubMed ID: 1369383
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia.
Bermejo P; Abad MJ; Díaz AM; Fernández L; De Santos J; Sanchez S; Villaescusa L; Carrasco L; Irurzun A
Planta Med; 2002 Feb; 68(2):106-10. PubMed ID: 11859457
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors.
Konoshima T; Takasaki M; Tatsumoto T; Kozuka M; Kasai R; Tanaka O; Nie RL; Tokuda H; Nishino H; Iwashima A
Biol Pharm Bull; 1994 May; 17(5):668-71. PubMed ID: 7920430
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of 6-O-acylated L-ascorbic acids possessing a straight- or branched-acyl chain on Epstein-Barr virus activation.
Uesato S; Kitagawa Y; Kaijima T; Tokuda H; Okuda M; Mou XY; Mukainaka T; Nishino H
Cancer Lett; 2001 May; 166(2):143-6. PubMed ID: 11311486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
